BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17219414)

  • 1. DNA methylation and immunohistochemical analysis of the S100A4 calcium binding protein in human prostate cancer.
    Rehman I; Goodarzi A; Cross SS; Leiblich A; Catto JW; Phillips JT; Hamdy FC
    Prostate; 2007 Mar; 67(4):341-7. PubMed ID: 17219414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer.
    Rehman I; Cross SS; Catto JW; Leiblich A; Mukherjee A; Azzouzi AR; Leung HY; Hamdy FC
    Prostate; 2005 Dec; 65(4):322-30. PubMed ID: 16015609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors.
    Rehman I; Cross SS; Azzouzi AR; Catto JW; Deloulme JC; Larre S; Champigneuille J; Fromont G; Cussenot O; Hamdy FC
    Br J Cancer; 2004 Aug; 91(4):739-44. PubMed ID: 15280928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypomethylation-induced expression of S100A4 in endometrial carcinoma.
    Xie R; Loose DS; Shipley GL; Xie S; Bassett RL; Broaddus RR
    Mod Pathol; 2007 Oct; 20(10):1045-54. PubMed ID: 17673926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma.
    Gupta S; Hussain T; MacLennan GT; Fu P; Patel J; Mukhtar H
    J Clin Oncol; 2003 Jan; 21(1):106-12. PubMed ID: 12506178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation.
    Rosty C; Ueki T; Argani P; Jansen M; Yeo CJ; Cameron JL; Hruban RH; Goggins M
    Am J Pathol; 2002 Jan; 160(1):45-50. PubMed ID: 11786397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation-associated silencing of S100A4 expression in human epidermal cancers.
    Li Y; Liu ZL; Zhang KL; Chen XY; Kong QY; Wu ML; Sun Y; Liu J; Li H
    Exp Dermatol; 2009 Oct; 18(10):842-8. PubMed ID: 19703228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines.
    Nakamura N; Takenaga K
    Clin Exp Metastasis; 1998 Jul; 16(5):471-9. PubMed ID: 10091942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of S100A4 gene encoding an S100-related calcium-binding protein in human bile duct adenocarcinoma cell lines: correlation of S100A4 expression and invasive growth in Matrigel Matrix.
    Katayama N; Murao S; Ajiki T; Kitazawa S; Onoyama H; Kuroda Y; Maeda S
    Int J Mol Med; 2000 Nov; 6(5):539-42. PubMed ID: 11029520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of S100A4 is closely related to the aggressiveness of gastric cancer.
    Cho YG; Nam SW; Kim TY; Kim YS; Kim CJ; Park JY; Lee JH; Kim HS; Lee JW; Park CH; Song YH; Lee SH; Yoo NJ; Lee JY; Park WS
    APMIS; 2003 May; 111(5):539-45. PubMed ID: 12887505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF-1α to a hypoxia-induced, methylation-free hypoxia response element of S100A4 gene.
    Horiuchi A; Hayashi T; Kikuchi N; Hayashi A; Fuseya C; Shiozawa T; Konishi I
    Int J Cancer; 2012 Oct; 131(8):1755-67. PubMed ID: 22287060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9.
    Saleem M; Kweon MH; Johnson JJ; Adhami VM; Elcheva I; Khan N; Bin Hafeez B; Bhat KM; Sarfaraz S; Reagan-Shaw S; Spiegelman VS; Setaluri V; Mukhtar H
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14825-30. PubMed ID: 16990429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypomethylation-induced expression of S100A4 increases the invasiveness of laryngeal squamous cell carcinoma.
    Liu J; Guo Y; Fu S; Yang M; Sun KL; Fu WN
    Oncol Rep; 2010 Apr; 23(4):1101-7. PubMed ID: 20204297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of metastasis-associated protein S100A4 (Mts1) in prostate cancer progression and chemoprevention regimens in an autochthonous mouse model.
    Saleem M; Adhami VM; Ahmad N; Gupta S; Mukhtar H
    Clin Cancer Res; 2005 Jan; 11(1):147-53. PubMed ID: 15671539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of SNCG, S100A4, S100A9 and LCN2 gene expression and DNA methylation in bladder cancer.
    Dokun OY; Florl AR; Seifert HH; Wolff I; Schulz WA
    Int J Cancer; 2008 Dec; 123(12):2798-807. PubMed ID: 18803290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
    Pulukuri SM; Rao JS
    Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of S100A2 and S100A4 in lung adenocarcinomas: clinicopathological significance, relationship to p53 and identification of their target genes.
    Matsubara D; Niki T; Ishikawa S; Goto A; Ohara E; Yokomizo T; Heizmann CW; Aburatani H; Moriyama S; Moriyama H; Nishimura Y; Funata N; Fukayama M
    Cancer Sci; 2005 Dec; 96(12):844-57. PubMed ID: 16367903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of cobalt chloride on S100A4 expression in human gastric cancer cell BGC823].
    Hua J; Fu H; Zhang RX; Chen DQ; Yan Y; Chen FJ; Sun KL; Sun XJ
    Yi Chuan; 2008 Dec; 30(12):1563-6. PubMed ID: 19073570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal deletion, promoter hypermethylation and downregulation of FYN in prostate cancer.
    Sørensen KD; Borre M; Ørntoft TF; Dyrskjøt L; Tørring N
    Int J Cancer; 2008 Feb; 122(3):509-19. PubMed ID: 17943724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.
    Rehman I; Azzouzi AR; Cross SS; Deloulme JC; Catto JW; Wylde N; Larre S; Champigneuille J; Hamdy FC
    Hum Pathol; 2004 Nov; 35(11):1385-91. PubMed ID: 15668896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.